Transanal down-to-up dissection of the distal rectum as a viable approach to achieve total mesorectal excision in laparoscopic sphincter-preserving surgery for rectal cancer near the anus: a study of short- and long-term outcomes of 127 consecutive patients from a single Japanese institution
Author:
Kagami Satoru1, Funahashi Kimihiko1, Koda Takamaru1, Ushigome Toshimitsu1, Kaneko Tomoaki1, Suzuki Takayuki1, Miura Yasuyuki1, Nagashima Yasuo1, Yoshida Kimihiko1, Kurihara Akiharu1
Affiliation:
1. Toho University Omori Medical Center
Abstract
Abstract
Purpose
In laparoscopic sphincter-preserving surgery (lap-SPS) for rectal cancer (RC), total mesorectal excision (TME) in low RC patients is difficult. This study aimed to evaluate the short- and long-term outcomes of transanal down-to-up dissection of the distal rectum to achieve TME in lap-SPS for RC near the anus.
Methods
A total of 137 consecutive patients with RC near the anus underwent lap-SPS, with either transanal rectal dissection under direct vision (TARD), which mobilized the most difficult portion of TME via the anus, or trans-anal TME (TaTME), which used an endoscopic system, between January 2006 and February 2021.
Results
A total of 127 consecutive patients (87 men), with a median age of 66 years (range: 33–86 years), were included. TARD and TaTME were performed in 51 (40.2%) and 76 (59.8%) patients, respectively. Preoperative treatment was performed in 41 (32.3%) patients. Although operative time in the transanal portion in the TaTME group was longer (p < 0.001), total operative time was unaffected. Median blood loss was lower in the TaTME group (p < 0.001). Postoperative complications developed in 56 (44.1%) patients. TME quality was good for almost all the patients and recurrence occurred in 18 patients (14.2%). The five-year overall survival and disease-free survival rates in the 127 patients were 90.4% and 83.2%, respectively.
Conclusion
Our data suggest that a transanal down-to-up dissection of the distal rectum might be a viable approach in lap-SPS for RC near the anus. Further studies are needed to examine the differences between TARD and TaTME.
Publisher
Research Square Platform LLC
Reference41 articles.
1. 1. van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, Bonjer HJ, COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14(3):210–218. https://doi.org/10.1016/S1470-2045(13)70016-0 2. 2. Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J, ALaCaRT Investigators (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314(13):1356–1363. https://doi.org/10.1001/jama.2015.12009 3. 3. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H (2015) Effect of laparoscopic-assisted resection vs open resection of Stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314(13):1346–1355. https://doi.org/10.1001/jama.2015.10529 4. 4. Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES, Lacy AM, Bemelman WA, Andersson J, Angenete E, Rosenberg J, Fuerst A, Haglind E, COLOR II Study Group (2015) A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 372(14):1324–1332. https://doi.org/10.1056/NEJMoa1414882 5. 5. Stevenson ARL, Solomon MJ, Brown CSB, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Wilson K, Hague W, Simes J, Australasian Gastro-Intestinal Trials Group (AGITG) (2019) ALaCaRT investigators. Disease-free Survival and local Recurrence After Laparoscopic-assisted Resection or open Resection for rectal Cancer: the Australasian laparoscopic Cancer of the rectum Randomized. Clinical Trial Ann Surg 269(4):596–602. https://doi.org/10.1097/SLA.0000000000003021
|
|